Jul 2026· Clinical and Experimental Obstetrics & Gynecology· Vol 53· 0 citations· 22 references
TL;DR
Increasing age, low BMI, increased bone turnover, increased bone turnover, reduced testosterone, and elevated lipoprotein(a) were identified as factors significantly associated with reduced BMD in postmenopausal women.
Abstract
Background:To analyze the bone mineral density (BMD) status of postmenopausal women, thereby providing a basis for precise clinical nursing interventions, an area that remains underexplored in tailored gerontological nursing practice.Methods:This was a retrospective and cross-sectional study. A total of 1375 postmenopausal women aged 45–59 years who underwent BMD examination at Jinhua Hospital of Zhejiang University from January 1, 2025, to December 31, 2025 were retrospectively enrolled. Demographic data, bone metabolism markers, sex hormones, blood lipids, and other relevant indices were collected. Participants were categorized into three groups based on BMD results: normal BMD, osteopenia, and osteoporosis. Intergroup comparisons were performed using the Kruskal-Wallis test, one-way analysis of variance (ANOVA), or the χ2 test. Independent associated factors were identified using multinomial logistic regression, and subgroup analyses were performed.Results:Subgroup analysis revealed that BMD decreased with increasing age (p < 0.001) and decreasing body mass index (BMI) (p < 0.001), and that BMD distribution also differed among occupational types (p = 0.001). Compared with the normal BMD group, univariate analysis and multinomial logistic regression showed that older age, lower BMI, lower serum calcium, and elevated alkaline phosphatase (ALP) were independently associated with osteopenia (p < 0.05 for all). Estradiol levels also showed a statistically significant but clinically negligible association (p = 0.035). Older age, lower BMI, elevated ALP, lower testosterone, and elevated lipoprotein(a) levels were identified as independent predictors for osteoporosis (p < 0.05 for all).Conclusions:Increasing age, low BMI, increased bone turnover, reduced testosterone, and elevated lipoprotein(a) were identified as factors significantly associated with reduced BMD in postmenopausal women.
Elevated SUA levels are correlated with higher BMD and a reduced risk of osteopenia and osteoporosis in T2DM patients, and BMI, E2, OCN, and SUA act as independent predictors of bone status in this patient population.
Shangjian Li, Weihong Lu, Xiumei Luo et al.· Journal of Diabetes Research· 0 citations
Increased levels of NLR and PLR correlate with diminished BMD, suggesting their potential as cost-effective biomarkers for osteoporosis risk assessment, and monitoring these indices could enhance early diagnosis and prevention strategies in at-risk populations.
Nasrin Bazgir, MohammadHossein Sahami Gilan, Aliashraf Mozafari et al.· Journal of Education and Hea...· 0 citations
The additional tested variables did not provide precisely estimated incremental associations in the prespecified age-sex-plus-one-variable models, and the tested complex classifiers did not materially improve internal discrimination over the age-sex benchmark.
Song Lu, Bo Wan, Chun-Sheng Qian et al.· BMC Musculoskeletal Disorder...· 0 citations
Postmenopausal status, menopause duration, older age, BMI, lack of exercise, low vitamin D intake, and fracture history were associated with higher odds of abnormal BMD, whereas regular exercise, dairy products, bean products, and calcium supplementation were protective.
Ming-Yue Jia, Ting-Zhi Chen, Shu-Wei Zhang et al.· Women & health· 0 citations
Older people with osteopenia, osteoporosis and fracture had lower visceral fat mass, lean mass, lean mass and waist circumference than normal people and LM, WC and VFM had the greatest effect on BMD and fracture in elderly diabetic.
Seyed Amirhossein Hosseini, N. Meftah, Mansor Babaei et al.· Caspian Journal of Internal...· 0 citations
No routinely measured biomarker demonstrated clinical utility for identifying BMD trajectory in this cohort of Saudi dual-energy X-ray absorptiometry patients, suggesting future studies with explicit treatment tracking and repeated bone-turnover measurements are required for confirmation.
L. Jambi, S. Kabrah· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.